Crestline Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54M | Sell |
|
|||||
|
2025
Q1 | $56.6M | Sell |
|
|||||
|
2024
Q4 | $87.9M | Sell |
|
|||||
|
2024
Q3 | $130M | Sell |
|
|||||
|
2024
Q2 | $111M | Sell |
|
|||||
|
2024
Q1 | $107M | Sell |
|
|||||
|
2023
Q4 | $121M | Sell |
|
|||||
|
2023
Q3 | $123M | Sell |
|
|||||
|
2023
Q2 | $180M | Sell |
|
|||||
|
2023
Q1 | $148M | Sell |
|
|||||
|
2022
Q4 | $191M | Sell |
|
|||||
|
2022
Q3 | $220M | Sell |
|
|||||
|
2022
Q2 | $220M | Hold |
|
|||||
|
2022
Q1 | $240M | Sell |
|
|||||
|
2021
Q4 | $344M | Hold |
|
|||||
|
2021
Q3 | $389M | Sell |
|
|||||
|
2021
Q2 | $638M | Sell |
|
|||||
|
2021
Q1 | $570M | Sell |
|
|||||
|
2020
Q4 | $339M | Buy |
|
|||||
|
2020
Q3 | $437M | Sell |
|
|||||
|
2020
Q2 | $330M | Sell |
|
|||||
|
2020
Q1 | $273M | Sell |
|
|||||
|
2019
Q4 | $339M | Hold |
|
|||||
|
2019
Q3 | $298M | Hold |
|
|||||
|
2019
Q2 | $404M | Hold |
|
|||||
|
2019
Q1 | $452M | Hold |
|
|||||
|
2018
Q4 | $402M | Sell |
|
|||||
|
2018
Q3 | $447M | Hold |
|
|||||
|
2018
Q2 | $314M | Hold |
|
|||||
|
2018
Q1 | $405M | Buy |
|
|||||
|
2017
Q4 | $322M | Buy |
|